Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tameka N. Jones"'
Autor:
Andrew J. Paladino, Janeane N. Anderson, Rebecca A. Krukowski, Teresa Waters, Mehmet Kocak, Carolyn Graff, Ryan Blue, Tameka N. Jones, Joanne Buzaglo, Gregory Vidal, Lee Schwartzberg, Ilana Graetz
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background Long-term use of adjuvant endocrine therapy (AET) among women with early-stage, hormone receptor-positive breast cancer significantly reduces the risk of hospitalizations, cancer recurrence, and mortality. AET is associated with a
Externí odkaz:
https://doaj.org/article/30f990f7f7304a9b8164d0826a65baab
Autor:
Andrew J. Paladino, Teresa M. Waters, Rebecca A. Krukowski, Ilana Graetz, Janeane N. Anderson, J. Carolyn Graff, Gregory A. Vidal, Tameka N. Jones, Lee S. Schwartzberg, Ryan Blue, Mehmet Kocak
Publikováno v:
Health Commun
Patient-provider communication is a critical component of healthcare and is associated with treatment quality and outcomes for women with breast cancer. This qualitative study examines similarities and differences in patient perspectives of communica
Autor:
Carolyn Graff, Janeane N. Anderson, Lee S. Schwartzberg, Ilana Graetz, Ryan Blue, Tameka N. Jones, Andrew J. Paladino, Gregory A. Vidal, Teresa M. Waters, Joanne S. Buzaglo, Rebecca A. Krukowski, Mehmet Kocak
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-12 (2019)
BMC Health Services Research
BMC Health Services Research
Background Long-term use of adjuvant endocrine therapy (AET) among women with early-stage, hormone receptor-positive breast cancer significantly reduces the risk of hospitalizations, cancer recurrence, and mortality. AET is associated with adverse sy
Autor:
Rebecca A. Krukowski, Janeane N. Anderson, Lee S. Schwartzberg, Andrea N. Curry, Gregory A. Vidal, Teresa M. Waters, Tameka N. Jones, J. Carolyn Graff, Andrew J. Paladino, Ilana Graetz
Publikováno v:
Journal of hospital management and health policy
Background: Women with hormone receptor-positive, early-stage breast cancer who adhere to adjuvant endocrine therapy (AET) reduce the risk of cancer recurrence and mortality. AET, however, is associated with adverse symptoms that often result in poor
Autor:
Janeane N. Anderson, Lee S. Schwartzberg, Gregory A. Vidal, Rebecca A. Krukowski, Ilana Graetz, Andrew J. Paladino, J. Carolyn Graff, Tameka N. Jones, Mehmet Kocack
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:A073-A073
Background: Women diagnosed with breast cancer transitioning from the active phase of treatment to the adjuvant phase of treatment experience fewer opportunities to receive support from their oncology team. During this period of time, the frequently
Publikováno v:
Journal of Clinical Oncology. 38:104-104
104 Background: Immunotherapy is a relatively new method of cancer treatment which has seen little research into its psychosocial side effects. A clearer understanding of the source of anxiety for those undergoing immunotherapy is crucial as anxiety
Autor:
Tameka N. Jones, Andrew J. Paladino, Gregory A. Vidal, Rebecca Krukowski, J. Carolyn Graff, Ryan Blue, Ilana Graetz, Lee Schwartzberg, Mehmet Kocak, Janeane Anderson
Publikováno v:
Cancer Research. 79:2428-2428
Background Adjuvant endocrine therapies (AETs) (e.g. tamoxifen and aromatase inhibitors (AIs) are almost always prescribed to early stage breast cancer (BrCa) patients as AETs have been shown to reduce risk of recurrence and mortality for women with
Autor:
Linda House, Maxwell Mulcahy, Julie Olson, Shauna McManus, Lee S. Schwartzberg, Tameka N. Jones, Nicholas James Power
Publikováno v:
Journal of Clinical Oncology. 37:91-91
91 Background: Immunotherapy & Me ( IO & Me) is an innovative program of supportive resources developed by Cancer Support Community to investigate and support the unique needs of immunotherapy patients. Here, we describe psychosocial distress and con